Genetic players in multiple system atrophy: Unfolding the nature of the beast

Neurobiology of Aging

Volumn 32, Issue 10, 2011, Pages 1924.e5-1924.e14

  Stemberger, Sylvia ^a   Scholz, Sonja W ^b,c   Singleton, Andrew B ^c   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alpha synuclein; Ataxia; Glial cytoplasmic inclusions; Multiple system atrophy; Neurodegeneration; Parkinsonism

Indexed keywords

ALCOHOL DEHYDROGENASE; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA SYNUCLEIN; FRAGILE X MENTAL RETARDATION PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUCINE RICH REPEAT KINASE 2; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE INDUCED PUTATIVE KINASE 1; PROTEIN KINASE; TAU PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACT A GENE; ADH1C GENE; ATAXIA; AUTOPSY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EIF4EBP1 GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; ICAM 1 GENE; IL 1ALPHA GENE; IL 1BETA GENE; IL 8 GENE; INFLAMMATION; LRRK2 GENE; MAPT GENE; MISSENSE MUTATION; OXIDATIVE STRESS; PARKIN GENE; PARKINSONISM; PEDIGREE ANALYSIS; PINK1 GENE; PRIORITY JOURNAL; REVIEW; SHY DRAGER SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; SLC1A4 GENE; SQSTM1 GENE; TNF GENE;

EID: 80051569267     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.04.001     Document Type: Review

References (101)

1. Abele M., Bürk K., Schöls L., Schwartz S., Besenthal I., Dichgans J., Zühlke C., Riess O., Klockgether T. The aetiology of sporadic adult-onset ataxia. Brain 2002, 125:961-968.
2. Abraham R., Sims R., Carroll L., Hollingworth P., O'Donovan M.C., Williams J., Owen M.J. An association study of common variation at the MAPT locus with late-onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet 2009, 150B:1152-1155.
3. Al-Chalabi A., Dürr A., Wood N.W., Parkinson M.H., Camuzat A., Hulot J.S., Morrison K.E., Renton A., Sussmuth S.D., Landwehrmeyer B.G., Ludolph A., Agid Y., Brice A., Leigh P.N., Bensimon G. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009, 4:e7114. NNIPPS Genetic Study Group.
4. Annic A., Devos D., Destée A., Defebvre L., Lacour A., Hurtevent J.F., Stojkovic T. Early dopasensitive Parkinsonism related to myotonic dystrophy type 2. Mov. Disord 2008, 23:2100-2101.
5. Bandmann O., Sweeney M.G., Daniel S.E., Wenning G.K., Quinn N., Marsden C.D., Wood N.W. Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Neurology 1997, 49:1598-1604.
6. Bandmann O., Wenning G.K., Quinn N.P., Harding A.E. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 1995, 59:557.
7. Berciano J., Ferrer I. Glial and neuronal cytoplasmic inclusions in familial olivopontocerebellar atrophy. Ann. Neurol 1996, 40:819-820.
8. Berciano J., Ferrer I. Glial cell cytoplasmic inclusions in SCA2 do not express alpha-synuclein. J. Neurol 2005, 252:742-744.
9. Berciano J., Infante J., García A., Polo J.M., Volpini V., Combarros O. Very late-onset Friedreich's ataxia with minimal GAA1 expansion mimicking multiple system atrophy of cerebellar type. Mov. Disord 2005, 20:1643-1645.
10. Brooks J.A., Houlden H., Melchers A., Islam A.J., Ding J., Li A., Paudel R., Revesz T., Holton J.L., Wood N., Lees A., Singleton A.B., Scholz S.W. Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol. Aging 2011, 32:548.e5-548.e7.
11. Brown R.C., Lockwood A.H., Sonawane B.R. Neurodegenerative diseases: an overview of environmental risk factors. Environ. Health Perspect 2005, 113:1250-1256.
12. Buervenich S., Sydow O., Carmine A., Zhang Z., Anvret M., Olson L. Alcohol dehydrogenase alleles in Parkinson's disease. Mov. Disord 2000, 15:813-818.
13. Cairns N.J., Atkinson P.F., Kovács T., Lees A.J., Daniel S.E., Lantos P.L. Apolipoprotein E e4 allele frequency in patients with multiple system atrophy. Neurosci. Lett 1997, 221:161-164.
14. Cho J.W., Kim S.Y., Park S.S., Jeon B.S. Spinocerebellar ataxia type 12 was not found in Korean Parkinsonian patients. Can. J. Neurol. Sci 2008, 35:488-490.
15. Cho J.W., Kim S.Y., Park S.S., Jeon B.S. The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy. Clin. Neurol 2009, 5:29-32.
16. Cho S., Kim C.H., Cubells J.F., Zabetian C.P., Hwang D.Y., Kim J.W., Cohen B.M., Biaggioni I., Robertson D., Kim K.S. Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy. Am. J. Med. Genet. A 2003, 120A:234-236.
17. Combarros O., Infante J., Llorca J., Berciano J. Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov. Disord 2003, 18:1385-1386.
18. Duda J.E., Giasson B.I., Chen Q., Gur T.L., Hurtig H.I., Stern M.B., Gollomp S.M., Ischiropoulos H., Lee V.M., Trojanowski J.Q. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol 2000, 157:1439-1445.
19. Factor S.A., Qian J., Lava N.S., Hubbard J.D., Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann. Neurol 2005, 57:462-463.
20. Farrer M., Kachergus J., Forno L., Lincoln S., Wang D.S., Hulihan M., Maraganore D., Gwinn-Hardy K., Wszolek Z., Dickson D., Langston J.W. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol 2004, 55:174-179.
21. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.M., Schüle B., Langston J.W., Middleton F.A., Ross O.A., Hulihan M., Gasser T., Farrer M.J. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007, 68:916-922.
22. Furiya Y., Hirano M., Kurumatani N., Nakamuro T., Matsumura R., Futamura N., Ueno S. Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res. Mol. Brain Res 2005, 138:178-181.
23. Gallyas F., Wolff J.R. Metal-catalyzed oxidation renders silver intensification selective. Applications for the histochemistry of diaminobenzidine and neurofibrillary changes. J. Histochem. Cytochem 1986, 34:1667-1672.
24. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J. Auton. Nerv. Syst 1998, 74:189-192.
25. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci 1999, 163:94-98.
26. Gilman S., Sima A.A., Junck L., Kluin K.J., Koeppe R.A., Lohman M.E., Little R. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann. Neurol 1996, 39:241-255.
27. Goedert M., Clavaguera F., Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010, 33:317-325.
28. Goker-Alpan O., Giasson B.I., Eblan M.J., Nguyen J., Hurtig H.I., Lee V.M., Trojanowski J.Q., Sidransky E. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006, 67:908-910.
29. Gwinn-Hardy K., Mehta N.D., Farrer M., Maraganore D., Muenter M., Yen S.H., Hardy J., Dickson D.W. Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol 2000, 99:663-672.
30. Hara K., Momose Y., Tokiguchi S., Shimohata M., Terajima K., Onodera O., Kakita A., Yamada M., Takahashi H., Hirasawa M., Mizuno Y., Ogata K., Goto J., Kanazawa I., Nishizawa M., Tsuji S. Multiplex families with multiple system atrophy. Arch. Neurol 2007, 64:545-551.
31. Hatano T., Kubo S., Sato S., Hattori N. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem 2009, 111:1075-1093.
32. Healy D.G., Abou-Sleiman P.M., Quinn N., Ahmadi K.R., Ozawa T., Kamm C., Wullner U., Oertel W.H., Burk K., Dupont E., Pellecchia M.T., Tolosa E., Gasser T., Holton J.L., Revesz T., Goldstein D.B., Lees A.J., Wood N.W. UCHL-1 gene in multiple system atrophy: a haplotype tagging approach. Mov. Disord 2005, 20:1338-1343.
33. Infante J., Llorca J., Berciano J., Combarros O. Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J. Neurol. Sci 2005, 228:11-13.
34. Ishizawa K., Komori T., Sasaki S., Arai N., Mizutani T., Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol 2004, 63:43-52.
35. Iwahashi K., Miyatake R., Tsuneoka Y., Matsuo Y., Ichikawa Y., Hosokawa K., Sato K., Hayabara T. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 1995, 58:263-264.
36. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W.B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H.A., Haass C. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 2002, 3:583-588.
37. Kamm C., Healy D.G., Quinn N.P., Wüllner U., Moller J.C., Schols L., Geser F., Burk K., Børglum A.D., Pellecchia M.T., Tolosa E., del Sorbo F., Nilsson C., Bandmann O., Sharma M., Mayer P., Gasteiger M., Haworth A., Ozawa T., Lees A.J., Short J., Giunti P., Holinski-Feder E., Illig T., Wichmann H.E., Wenning G.K., Wood N.W., Gasser T. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain 2005, 128:1855-1860. European Multiple System Atrophy Study Group.
38. Khan N.L., Giunti P., Sweeney M.G., Scherfler C., Brien M.O., Piccini P., Wood N.W., Lees A.J. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Mov. Disord 2005, 20:1115-1119.
39. Kim H.S., Lee M.S. Frequencies of single nucleotide polymorphism in alcohol dehydrogenase7 gene in patients with multiple system atrophy and controls. Mov. Disord 2003, 18:1065-1067.
40. Kim J.Y., Kim S.Y., Kim J.M., Kim Y.K., Yoon K.Y., Kim J.Y., Lee B.C., Kim J.S., Paek S.H., Park S.S., Kim S.E., Jeon B.S. Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism. Neurology 2009, 72:1385-1389.
41. Lantos P.L. The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol 1998, 57:1099-1111.
42. Lantos P.L., Papp M.I. Cellular pathology of multiple system atrophy: a review. J. Neurol. Neurosurg. Psychiatry 1994, 57:129-133.
43. Lim S.Y., Wadia P., Wenning G.K., Lang A.E. Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov. Disord 2009, 24:1407-1409.
44. Lin I.S., Wu R.M., Lee-Chen G.J., Shan D.E., Gwinn-Hardy K. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat. Disord 2007, 13:246-249.
45. Lincoln S.J., Ross O.A., Milkovic N.M., Dickson D.W., Rajput A., Robinson C.A., Papapetropoulos S., Mash D.C., Farrer M.J. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat. Disord 2007, 13:340-342.
46. Lwin A., Orvisky E., Goker-Alpan O., LaMarca M.E., Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab 2004, 81:70-73.
47. Morris H.R., Schrag A., Nath U., Burn D., Quinn N.P., Daniel S., Wood N.W., Lees A.J. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci. Lett 2001, 312:118-120.
48. Morris H.R., Vaughan J.R., Datta S.R., Bandopadhyay R., Rohan De Silva H.A., Schrag A., Cairns N.J., Burn D., Nath U., Lantos P.L., Daniel S., Lees A.J., Quinn N.P., Wood N.W. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology 2000, 55:1918-1920.
49. Muenter M.D., Forno L.S., Hornykiewicz O., Kish S.J., Maraganore D.M., Caselli R.J., Okazaki H., Howard F.M., Snow B.J., Calne D.B. Hereditary form of parkinsonism-dementia. Ann. Neurol 1998, 43:768-781.
50. Nee L.E., Gomez M.R., Dambrosia J., Bale S., Eldridge R., Polinsky R.J. Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin. Auton. Res 1991, 1:9-13.
51. Nicholl D.J., Bennett P., Hiller L., Bonifati V., Vanacore N., Fabbrini G., Marconi R., Colosimo C., Lamberti P., Stocchi F., Bonuccelli U., Vieregge P., Ramsden D.B., Meco G., Williams A.C. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 1999, 53:1415-1421.
52. Nirenberg M.J., Libien J., Vonsattel J.P., Fahn S. Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation. Mov. Disord 2007, 22:251-254.
53. Nishimura M., Kawakami H., Komure O., Maruyama H., Morino H., Izumi Y., Nakamura S., Kaji R., Kuno S. Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov. Disord 2002, 17:808-811.
54. Nishimura M., Kuno S., Kaji R., Kawakami H. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov. Disord 2005, 20:1031-1033.
55. Nishimura M., Kuno S., Kaji R., Kawakami H. Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci. Lett 2005, 374:218-221.
56. Nuytemans K., Theuns J., Cruts M., Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat 2010, 31:763-780.
57. Ozawa T., Healy D.G., Abou-Sleiman P.M., Ahmadi K.R., Quinn N., Lees A.J., Shaw K., Wullner U., Berciano J., Moller J.C., Kamm C., Burk K., Josephs K.A., Barone P., Tolosa E., Goldstein D.B., Wenning G., Geser F., Holton J.L., Gasser T., Revesz T., Wood N.W. The alpha-synuclein gene in multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 2006, 77:464-467.
58. Ozawa T., Takano H., Onodera O., Kobayashi H., Ikeuchi T., Koide R., Okuizumi K., Shimohata T., Wakabayashi K., Takahashi H., Tsuji S. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci. Lett 1999, 270:110-112.
59. Ozelius L.J., Foroud T., May S., Senthil G., Sandroni P., Low P.A., Reich S., Colcher A., Stern M.B., Ondo W.G., Jankovic J., Huang N., Tanner C.M., Novak P., Gilman S., Marshall F.J., Wooten G.F., Chelimsky T.C., Shults C.W. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov. Disord 2007, 22:546-549. North American Multiple System Atrophy Study Group.
60. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci 1989, 94:79-100.
61. Planté-Bordeneuve V., Bandmann O., Wenning G., Quinn N.P., Daniel S.E., Harding A.E. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy. Mov. Disord 1995, 10:277-278.
62. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di I.G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
63. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol 1998, 43:815-825.
64. Quinn N. Multiple system atrophy-the nature of the beast. J. Neurol. Neurosurg. Psychiatry Suppl 1989, 78-89.
65. Ross O.A., Toft M., Whittle A.J., Johnson J.L., Papapetropoulos S., Mash D.C., Litvan I., Gordon M.F., Wszolek Z.K., Farrer M.J., Dickson D.W. Lrrk2 and Lewy body disease. Ann. Neurol 2006, 59:388-393.
66. Ross O.A., Vilariño-Güell C., Wszolek Z.K., Farrer M.J., Dickson D.W. Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann. Neurol 2010, 67:414-415.
67. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet 2009, 41:1303-1307.
68. Schmitt I., Wüllner U., Healy D.G., Wood N.W., Kölsch H., Heun R. The ADH1C stop mutation in multiple system atrophy patients and healthy probands in the United Kingdom and Germany. Mov. Disord 2006, 21:2034.
69. Schöls L., Bauer P., Schmidt T., Schulte T., Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
70. Scholz S.W., Houlden H., Schulte C., Sharma M., Li A., Berg D., Melchers A., Paudel R., Gibbs J.R., Simón-Sánchez J., Paisan-Ruiz C., Bras J., Ding J., Chen H., Traynor B.J., Arepalli S., Zonozi R.R., Revesz T., Holton J., Wood N., Lees A., Oertel W., Wullner U., Goldwurm S., Pellecchia M.T., Illig T., Riess O., Fernandez H.H., Rodriguez R.L., Okun M.S., Poewe W., Wenning G.K., Hardy J.A., Singleton A.B., Gasser T., del Sorbo F., Schneider S., Bhatia K.P. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol 2009, 65:610-614.
71. Segarane B., Li A., Paudel R., Scholz S., Neumann J., Lees A., Revesz T., Hardy J., Mathias C.J., Wood N.W., Holton J., Houlden H. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009, 72:1185-1186.
72. Shibao C., Garland E.M., Gamboa A., Vnencak-Jones C.L., Van Woeltz M., Haines J.L., Yu C., Biaggioni I. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin. Auton. Res 2008, 18:13-19.
73. Shults C.W., Rockenstein E., Crews L., Adame A., Mante M., Larrea G., Hashimoto M., Song D., Iwatsubo T., Tsuboi K., Masliah E. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci 2005, 25:10689-10699.
74. Sidransky E. Heterozygosity for a Mendelian disorder as a risk factor for complex disease. Clin. Genet 2006, 70:275-282.
75. Simón-Sánchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Krüger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., van der Gwinn K., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet 2009, 41:1308-1312.
76. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
77. Soma H., Yabe I., Takei A., Fujiki N., Yanagihara T., Sasaki H. Heredity in multiple system atrophy. J. Neurol. Sci 2006, 240:107-110.
78. Soma H., Yabe I., Takei A., Fujiki N., Yanagihara T., Sasaki H. Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Mov. Disord 2008, 23:1161-1167.
79. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett 1998, 251:205-208.
80. Stefanova N., Bücke P., Duerr S., Wenning G.K. Multiple system atrophy: an update. Lancet Neurol 2009, 8:1172-1178.
81. Tan E.K., Skipper L., Chua E., Wong M.C., Pavanni R., Bonnard C., Kolatkar P., Liu J.J. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease. Mov. Disord 2006, 21:997-1001.
82. Thacker E.L., Ascherio A. Familial aggregation of Parkinson's disease: a meta-analysis. Mov. Disord 2008, 23:1174-1183.
83. Trojanowski J.Q., Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. Appl. Neurobiol 2007, 33:615-620. Neuropathology Working Group on MSA.
84. Vanacore N. Epidemiological evidence on multiple system atrophy. J. Neural Transm 2005, 112:1605-1612.
85. Vanacore N., Bonifati V., Fabbrini G., Colosimo C., De Michele G., Marconi R., Stocchi F., Nicholl D., Bonuccelli U., De Mari M., Vieregge P., Meco G. Case-control study of multiple system atrophy. Mov. Disord 2005, 20:158-163. ESGAP Consortium.
86. Vidal J.S., Vidailhet M., Derkinderen P., Tzourio C., Alpérovitch A. Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy. J. Neurol 2010, 257:1388-1393.
87. Vidal J.S., Vidailhet M., Elbaz A., Derkinderen P., Tzourio C., Alpérovitch A. Risk factors of multiple system atrophy: a case-control study in French patients. Mov. Disord 2008, 23:797-803.
88. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett 1998, 249:180-182.
89. Waters C.H., Miller C.A. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann. Neurol 1994, 35:59-64.
90. Wenning G.K., Colosimo C., Geser F., Poewe W. Multiple system atrophy. Lancet Neurol 2004, 3:93-103.
91. Wenning G.K., Stefanova N., Jellinger K.A., Poewe W., Schlossmacher M.G. Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol 2008, 64:239-246.
92. Wenning G.K., Wagner S., Daniel S., Quinn N.P. Multiple system atrophy: sporadic or familial?. Lancet 1993, 342:681.
93. Wider C., Vilariño-Güell C., Jasinska-Myga B., Heckman M.G., Soto-Ortolaza A.I., Cobb S.A., Aasly J.O., Gibson J.M., Lynch T., Uitti R.J., Wszolek Z.K., Farrer M.J., Ross O.A. Association of the MAPT locus with Parkinson's disease. Eur. J. Neurol 2010, 17:483-486.
94. Wullner U., Abele M., Schmitz-Huebsch T., Wilhelm K., Benecke R., Deuschl G., Klockgether T. Probable multiple system atrophy in a German family. J. Neurol. Neurosurg. Psychiatry 2004, 75:924-925.
95. Wullner U., Schmitt I., Kammal M., Kretzschmar H.A., Neumann M. Definite multiple system atrophy in a German family. J. Neurol. Neurosurg. Psychiatry 2009, 80:449-450.
96. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419-432.
97. Yabe I., Soma H., Takei A., Fujik N., Sasaki H. No association between FMR1 premutations and multiple system atrophy. J. Neurol 2004, 251:1411-1412.
98. Yazawa I., Giasson B.I., Sasaki R., Zhang B., Joyce S., Uryu K., Trojanowski J.Q., Lee V.M. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005, 45:847-859. [PubMed: 15797547].
99. Yu C.E., Bird T.D., Bekris L.M., Montine T.J., Leverenz J.B., Steinbart E., Galloway N.M., Feldman H., Woltjer R., Miller C.A., Wood E.M., Grossman M., McCluskey L., Clark C.M., Neumann M., Danek A., Galasko D.R., Arnold S.E., Chen-Plotkin A., Karydas A., Miller B.L., Trojanowski J.Q., Lee V.M., Schellenberg G.D., Van Deerlin V.M. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch. Neurol 2010, 67:161-170.
100. Yun J.Y., Lee W.W., Lee J.Y., Kim H.J., Park S.S., Jeon B.S. SNCA variants and multiple system atrophy. Ann. Neurol 2010, 67:554-555.
101. Zhang J., Montine T.J., Smith M.A., Siedlak S.L., Gu G., Robertson D., Perry G. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism Relat. Disord 2002, 8:165-170.